antisense oligonucleotides PKC-delta (Isis)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameantisense oligonucleotides PKC-delta (Isis)
Drug Alias NameISIS-13513ISIS-13514
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionProtein kinase C delta inhibitorsAntisense oligonucleotide inhibitorsAnticancer protein kinase inhibitors +[4] 
TargetsProtein kinase C delta
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIonis Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A